We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Hormel Foods
HRL
$13.8B
| $66.3M | 0.08% |
1,554,435
+203,436
| +15% | +$8.77M |
|
277
ITT
ITT
$19.1B
| $66.3M | 0.08% |
1,373,207
-352,140
| -20% | -$18.6M |
|
278
Match Group
MTCH
$8.55B
| $66.2M | 0.08% |
1,548,748
+637,600
| +70% | +$29.3M |
|
279
NorthWestern Energy
NWE
$4.43B
| $66M | 0.08% |
1,109,960
+57,380
| +5% | +$3.52M |
|
280
Prologis
PLD
$133B
| $65.9M | 0.08% |
1,122,684
-52,558
| -4% | -$3.41M |
|
281
Graham Holdings Company
GHC
$5.02B
| $65.9M | 0.08% |
102,824
+7,055
| +7% | +$4.36M |
|
282
Oshkosh
OSK
$9.59B
| $65.8M | 0.08% |
1,072,751
-682,282
| -39% | -$43.7M |
|
283
PVH
PVH
$4.04B
| $65.3M | 0.08% |
702,383
-74,839
| -10% | -$8.57M |
|
284
Starbucks
SBUX
$120B
| $64.6M | 0.07% |
1,002,880
+558,551
| +126% | +$35M |
|
285
Intercontinental Exchange
ICE
$84.4B
| $64.2M | 0.07% |
852,308
+116,387
| +16% | +$8.92M |
|
286
Canadian National Railway
CNI
$76.6B
| $64.2M | 0.07% |
866,994
+329,082
| +61% | +$27.3M |
|
287
Carnival Corporation Ltd
CCL
$39.7B
| $64.1M | 0.07% |
1,299,630
+520,244
| +67% | +$29.8M |
|
|
HDS
288
DELISTED
HD Supply Holdings, Inc.
HDS
| $63.3M | 0.07% |
1,687,176
-1,669,583
| -50% | -$64.3M |
|
289
Air Products & Chemicals
APD
$67.6B
| $63M | 0.07% |
393,402
-63,538
| -14% | -$10.1M |
|
290
Jazz Pharmaceuticals
JAZZ
$16.7B
| $62.4M | 0.07% |
503,300
+158,987
| +46% | +$23.6M |
|
291
Trane Technologies
TT
$106B
| $62.4M | 0.07% |
683,750
-487,759
| -42% | -$47.9M |
|
292
Bruker
BRKR
$8.14B
| $62.3M | 0.07% |
2,092,631
-151,163
| -7% | -$4.77M |
|
293
Canadian Natural Resources
CNQ
$93.8B
| $62.3M | 0.07% |
5,273,065
-1,626,161
| -24% | -$21.9M |
|
|
MASI
294
DELISTED
Masimo
MASI
| $62.2M | 0.07% |
578,970
+159,937
| +38% | +$17.8M |
|
|
XLNX
295
DELISTED
Xilinx Inc
XLNX
| $61.5M | 0.07% |
721,877
-85,307
| -11% | -$7.13M |
|
296
Boston Scientific
BSX
$71.5B
| $61.4M | 0.07% |
1,736,857
-708,505
| -29% | -$25.7M |
|
297
Dover
DOV
$28.4B
| $61.1M | 0.07% |
861,214
+570,676
| +196% | +$46.6M |
|
298
H&R Block
HRB
$5.86B
| $61M | 0.07% |
2,405,238
+977,811
| +69% | +$26.1M |
|
299
Eversource Energy
ES
$27.2B
| $59.5M | 0.07% |
914,271
+68,201
| +8% | +$4.44M |
|
300
Maximus
MMS
$3.1B
| $59.4M | 0.07% |
912,443
+6,355
| +0.7% | +$418K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.